Skip to main content
$47.75 -$1.02 (-2.1%)

04:00 PM EST on 01/27/23

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

CAPS Rating: No stars

Current Price $47.75 Mkt Cap $4.6B
Open $48.51 P/E Ratio 0.00
Prev. Close $47.75 Div. (Yield) $0.00 (0.0%)
Daily Range $47.74 - $49.30 Volume 583,385
52-Wk Range $42.42 - $66.00 Avg. Daily Vol. 559,174

Caps

How do you think NASDAQ:ITCI will perform against the market?

Add Stock to CAPS Watchlist

All Players

40 Outperform
6 Underperform
 

All-Star Players

8 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ITCI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (49.17)
Submitted February 03, 2020

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market… More

Hendrickson71 (< 20)
Submitted January 06, 2016

Come on sugar factory, come down to earth already, Let's see some $40s this week,

NASDAQ:ITCI Summary

Fools bullish on NASDAQ:ITCI are also bullish on:

Fools bearish on NASDAQ:ITCI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ITCI.

Recs

2
Member Avatar odocoileus (49.17) Submitted: 2/2/2020 7:00:11 PM : Outperform Start Price: $12.32 NASDAQ:ITCI Score: +261.30

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market size or marketing muscle, it's a crapshoot for me whether the drug will take off. So here we are. ITCI has a new class of drug in a huge indication. I'm hanging on expecting big things. Tell me what I'm missing.

Recs

1
Member Avatar emtking (38.63) Submitted: 12/13/2019 1:05:50 PM : Outperform Start Price: $12.60 NASDAQ:ITCI Score: +254.07

New drug for bipolar disorder looks as close to a sure thing as there can be going into an FDA decision date of December 278th or sooner, 2019.

Recs

1
Member Avatar LifeScientist (22.23) Submitted: 2/17/2016 2:37:17 PM : Outperform Start Price: $30.57 NASDAQ:ITCI Score: -53.30

watch 27 is an entry

Leaderboard

Find the members with the highest scoring picks in ITCI.

Score Leader

baselineace

baselineace (28.24) Score: +371.97

Sometimes you just get lucky?

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
odocoileus 49.17 12/11/2019 Outperform 5Y $12.32 +291.07% +29.78% +261.30 1 Comment
emtking 38.63 12/13/2019 Outperform 5Y $12.60 +282.38% +28.31% +254.07 1 Comment
derbydog85 56.36 12/23/2016 Outperform 5Y $15.62 +208.45% +80.67% +127.79 0 Comment
warrenout 28.98 9/30/2016 Outperform 3M $15.41 +212.65% +88.90% +123.75 0 Comment
joe508mama 29.84 9/30/2016 Outperform 5Y $15.41 +212.65% +88.90% +123.75 0 Comment
jmdor2222 84.49 9/29/2016 Outperform 5Y $15.49 +211.04% +89.01% +122.02 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. km00nster < 20 9/21/2015 Underperform 5Y $50.63 -4.84% +107.85% +112.69 1 Comment
Hendrickson71 < 20 1/7/2016 Underperform 3W $48.05 +0.27% +108.55% +108.28 1 Comment
Dananator < 20 8/7/2020 Outperform 5Y $20.97 +129.81% +21.94% +107.88 0 Comment
stockgripes 99.39 9/16/2015 Underperform 5Y $45.15 +6.71% +103.98% +97.27 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ITCI.